Azmi Nabulsi, Chief Operating Officer at Phathom Pharmaceuticals, Inc. (PHAT), sold 1,118 shares at $8.00 ($9K) on 2024-12-19, disclosed to the SEC on 2024-12-20.
Open-market sale of $9k PHAT by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PHAT | BUY | 2023-04-11 | $83K | — | Filing → |
| PHAT | BUY | 2022-05-16 | $163K | — | Filing → |
| PHAT | SELL | 2021-05-04 | $1.1M | — | Filing → |